Exhale

The official blog of the Lung Institute.

New Frontier: How the Moon Landing Inspires Stem Cell Therapy for COPD

14 Dec 2016
| Under COPD, Lifestyle | Posted by | 4 Comments
New Frontier: How the Moon Landing Inspires Stem Cell Therapy for COPD

On July 20th, 1969 America did the impossible: it landed two men on the moon. To say this was an unfathomable concept for its time would be an understatement. In a time where basic computers filled entire buildings, the technology and know-how to launch a manned flight seemed decades beyond our grasp.

In truth, the Apollo Program was an extraordinary undertaking, exorbitantly expensive and on its surface only justified by the intensity of America’s competition with the Soviet Union. In 1967, two years before the Apollo 11 mission would land Buzz Aldrin and Neil Armstrong safely on the Moon’s surface, the Apollo 1 spacecraft developed a cabin fire during a launch rehearsal test, killing all three crew members aboard. Spaceflight could be a lethal game of trial-and-error, and a single miscalculation could mean the difference between life and death.

In one of the seminal triumphs of mankind, America pushed the bounds of innovation as the world watched in awe. It had conquered a new frontier. And though the Space Race ended in 1972, today we face a new frontier in the field of medicine – treating chronic obstructive pulmonary disease (COPD)–and thanks to clinics such as the Lung Institute (lunginstitute.com) the solution may have just landed.

Across the globe 600 million people suffer from COPD, and that number is rising. As a degenerative lung disease that develops from prolonged smoking or extended exposure to other air pollutants, a declining quality of life is an unfortunate reality for those with lung disease. With no known cure, treatment options are often disappointingly limited, and traditional medications fail to address more than the relief of symptoms.

Today in the field of medicine, something exciting is happening. Using stem cells extracted from a patient’s own blood or bone marrow, clinics like the Lung Institute are using these specialized cells to promote the body’s natural healing process, helping to relieve inflammation within the lungs and slow disease progression. Addressing COPD, interstitial lung disease (ILD) and pulmonary fibrosis, stem cell therapy is poised to challenge the status quo of traditional treatment options, and bring a higher quality of life for those with chronic lung disease.

As the field of regenerative medicine has grown and advanced, the Lung Institute—which currently specializes in the treatment of lung disease—has operated for over three years, and has worked to increase the quality of life of over 3,000 patients. Proud to exhibit an 83% success rate, the Lung Institute lives by the tenet of “pushing the status quo” in order to bring hope to people who may otherwise have given up.

Whether in medicine or spaceflight, innovation takes courage, not only to visualize the impossible, but to create it. For those with the memory of where they were when America first landed on the Moon, the feeling that anything was possible was inescapable. We had seen the impossible accomplished right before our eyes.

Although at times, the conceit of man can serve to be the catalyst of our own downfall, when combined with the bold and pioneering spirit synonymous with American ingenuity, history is made. The next frontier is neither Mars nor the outer limits of the universe; it is our health. As we continue to push innovation for the benefit of mankind, we are guided by the immortal words of John F. Kennedy:

“We choose to go to the moon in this decade and do the other things, not because they are easy, but because they are hard.”

And that is the American way.

If you or someone you know is interested in learning more about stem cell therapy for COPD, interstitial lung disease or pulmonary fibrosis, please contact us or call (800) 729-3065.

4 Comments

  1. PB

    7 months ago

    Dear Richard,

    Thanks for your comment and questions. The Lung Institute is not conducting clinical trials, which would involve a control group who receives a placebo. The Lung Institute does not give a placebo to their patients receiving stem cell therapy. However, we are providing stem cell therapy under the regulation of the IRB for the protection of our patients while we’re collecting research data for further knowledge and to better help our patients. If you have any other questions regarding stem cell therapy, we would be happy to answer them one-on-one over the phone. Feel free to contact us at (855) 313-1149. We look forward to hearing from you soon.

    Kind Regards,

    The Lung Institute

  2. Richard Perkins

    7 months ago

    Any research test looking for subject?
    How do we hear about test for copd volunteers.

  3. PB

    8 months ago

    Dear Keith,

    First and foremost, we’re sorry to hear about the challenges you have been facing with sarcoidosis of the lungs. Like you, many people with pulmonary sarcoidosis take multiple medications. Unfortunately, at this time, insurance companies and Medicare don’t cover treatment. However, we’re hopeful that treatment will be covered by insurance companies in the near future. Keep in mind that it will take some time before the insurance companies see a financial benefit in their favor and then decide to cover it. We’re happy to answer your questions about stem cell therapy at any time, so feel free to contact us at (855) 313-1149. Also, feel free to keep checking-in with our blog to read articles on a variety of topics, such as foods to try, tips to improve blood oxygen levels and helpful tips for people with chronic lung diseases.

    Kind Regards,

    The Lung Institute

  4. Keith Stone

    8 months ago

    I have Sarcoidosis of the Lungs. It’s miserable. I used to be a very good athlete as a young man. A distance runner in fact. I found out 16 years ago I was afflicted with this. I’m on everything under the sun. I’ve been on Methotrexate before for a few years. I’m on Prednisone.10mg ,Advair ,Spiriva, Albuteral and I nebulize. Coming up with 7 to 14k is not possible for me for the stem cell treatment. I’m on Medicare and as you know it won’t cover it.

Your Comment

Your email address will not be published.



* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.